| Value | ₹1,842 Cr |
|---|
BSE filing, NSE: PNCINFRA. Summary written from the filing by ALFA Finder's alert engine.
PNC Infratech Ltd: key numbers
- Share price
- ₹133.98
- Market cap
- ₹3,437 Cr
- Revenue (annual)
- ₹5,368 Cr
- Net profit (annual)
- ₹831.8 Cr
- P/E (TTM)
- 5.5×Sector 32.4×
- Promoter holding
- 56.25%+0.18% QoQ
- FII holding
- 8.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from PNC Infratech Ltd
All →PNC Infratech Earnings Call Transcript: Key Takeaways
PNC reports strong revenue growth but remains under pressure from a temporary NHAI debarment stay and solar project cancellation.
- Call
- Guides 25% growth
PNC Infratech Investor Presentation: Key Takeaways
Q2FY27 standalone revenue Rs1,146cr (+17%), EBITDA margin 12.1% (-180bps), PAT Rs73cr (-16%). H1 revenue +26%, PAT +106%. Orderbook Rs14,871cr.
PNC Infratech Results Update
PNC Infratech issued a press release highlighting unaudited Q2 and H1 FY27 results, including standalone Q2 revenue of Rs.1146 Cr. Figures include NHAI arbitration awards and HAM monetisation gains.
PNC Infratech Q2 FY27 Results: Net Profit ₹114.7 Cr, Down 46.8% YoY
PNC Infratech Ltd reported revenue from operations of ₹1,322 Cr (+17.3% YoY) and net profit of ₹114.7 Cr (-46.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹114.7 Cr · -46.8% YoY
PNC Infratech Board Meeting Date
PNC Infratech has scheduled a board meeting on November 28, 2026, to consider and approve the standalone and consolidated financial results for the half-year period.
PNC Infratech Other Announcement
PNC Infratech informed exchanges that Crisil ESG Ratings assigned the company an ESG rating of 'Crisil ESG 53' based on public domain data.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.